Context-specific GITR agonism potentiates anti-PD-L1 and CD40-based immuno- chemotherapy combination in heterogeneous pancreatic tumors https://www.biorxiv.org/content/10.1101/2023.06.16.545301v1?med=mas
Context-specific GITR agonism potentiates anti-PD-L1 and CD40-based immuno- chemotherapy combination in heterogeneous pancreatic tumors https://www.biorxiv.org/content/10.1101/2023.06.16.545301v1?med=mas